CD86 and neoplasm: Human tumor cells and tumor-associated APCs often express high levels of PD-L1, PD-L2, ICOS-L, and B7-H3, which causes high co-inhibitory signals that are accompanied by a low CD28 co-stimulation of T cells, which is itself caused by low to absent CD80 and/or CD86 signals [16,17,18,19].